245 related articles for article (PubMed ID: 19109891)
1. An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan.
Ayalon G; Davis JQ; Scotland PB; Bennett V
Cell; 2008 Dec; 135(7):1189-200. PubMed ID: 19109891
[TBL] [Abstract][Full Text] [Related]
2. Ankyrin-B interactions with spectrin and dynactin-4 are required for dystrophin-based protection of skeletal muscle from exercise injury.
Ayalon G; Hostettler JD; Hoffman J; Kizhatil K; Davis JQ; Bennett V
J Biol Chem; 2011 Mar; 286(9):7370-8. PubMed ID: 21186323
[TBL] [Abstract][Full Text] [Related]
3. Obscurin is required for ankyrinB-dependent dystrophin localization and sarcolemma integrity.
Randazzo D; Giacomello E; Lorenzini S; Rossi D; Pierantozzi E; Blaauw B; Reggiani C; Lange S; Peter AK; Chen J; Sorrentino V
J Cell Biol; 2013 Feb; 200(4):523-36. PubMed ID: 23420875
[TBL] [Abstract][Full Text] [Related]
4. Dystrophin, utrophin and beta-dystroglycan expression in skeletal muscle from patients with Becker muscular dystrophy.
Kawajiri M; Mitsui T; Kawai H; Kobunai T; Tsuchihashi T; Saito S
J Neuropathol Exp Neurol; 1996 Aug; 55(8):896-903. PubMed ID: 8759779
[TBL] [Abstract][Full Text] [Related]
5. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.
Côté PD; Moukhles H; Lindenbaum M; Carbonetto S
Nat Genet; 1999 Nov; 23(3):338-42. PubMed ID: 10610181
[TBL] [Abstract][Full Text] [Related]
6. Muscle dystroglycan organizes the postsynapse and regulates presynaptic neurotransmitter release at the Drosophila neuromuscular junction.
Bogdanik L; Framery B; Frölich A; Franco B; Mornet D; Bockaert J; Sigrist SJ; Grau Y; Parmentier ML
PLoS One; 2008 Apr; 3(4):e2084. PubMed ID: 18446215
[TBL] [Abstract][Full Text] [Related]
7. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex.
Crosbie RH; Lebakken CS; Holt KH; Venzke DP; Straub V; Lee JC; Grady RM; Chamberlain JS; Sanes JR; Campbell KP
J Cell Biol; 1999 Apr; 145(1):153-65. PubMed ID: 10189375
[TBL] [Abstract][Full Text] [Related]
8. Transgenic overexpression of dystroglycan does not inhibit muscular dystrophy in mdx mice.
Hoyte K; Jayasinha V; Xia B; Martin PT
Am J Pathol; 2004 Feb; 164(2):711-8. PubMed ID: 14742274
[TBL] [Abstract][Full Text] [Related]
9. Studying the role of dystrophin-associated proteins in influencing Becker muscular dystrophy disease severity.
van den Bergen JC; Wokke BH; Hulsker MA; Verschuuren JJ; Aartsma-Rus AM
Neuromuscul Disord; 2015 Mar; 25(3):231-7. PubMed ID: 25633150
[TBL] [Abstract][Full Text] [Related]
10. A and B utrophin in human muscle and sarcolemmal A-utrophin associated with tumours.
Sewry CA; Nowak KJ; Ehmsen JT; Davies KE
Neuromuscul Disord; 2005 Nov; 15(11):779-85. PubMed ID: 16198105
[TBL] [Abstract][Full Text] [Related]
11. Novel interactions of ankyrins-G at the costameres: the muscle-specific Obscurin/Titin-Binding-related Domain (OTBD) binds plectin and filamin C.
Maiweilidan Y; Klauza I; Kordeli E
Exp Cell Res; 2011 Apr; 317(6):724-36. PubMed ID: 21223964
[TBL] [Abstract][Full Text] [Related]
12. Mini-dystrophin efficiently incorporates into the dystrophin protein complex in living cells.
Draviam RA; Wang B; Li J; Xiao X; Watkins SC
J Muscle Res Cell Motil; 2006; 27(1):53-67. PubMed ID: 16496225
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of the dystrophin anchoring site on beta-dystroglycan.
Jung D; Yang B; Meyer J; Chamberlain JS; Campbell KP
J Biol Chem; 1995 Nov; 270(45):27305-10. PubMed ID: 7592992
[TBL] [Abstract][Full Text] [Related]
14. The 8th and 9th tandem spectrin-like repeats of utrophin cooperatively form a functional unit to interact with polarity-regulating kinase PAR-1b.
Yamashita K; Suzuki A; Satoh Y; Ide M; Amano Y; Masuda-Hirata M; Hayashi YK; Hamada K; Ogata K; Ohno S
Biochem Biophys Res Commun; 2010 Jan; 391(1):812-7. PubMed ID: 19945424
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological rescue of the dystrophin-glycoprotein complex in Duchenne and Becker skeletal muscle explants by proteasome inhibitor treatment.
Assereto S; Stringara S; Sotgia F; Bonuccelli G; Broccolini A; Pedemonte M; Traverso M; Biancheri R; Zara F; Bruno C; Lisanti MP; Minetti C
Am J Physiol Cell Physiol; 2006 Feb; 290(2):C577-82. PubMed ID: 16192300
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol depletion uncouples β-dystroglycans from discrete sarcolemmal domains, reducing the mechanical activity of skeletal muscle.
Vega-Moreno J; Tirado-Cortes A; Álvarez R; Irles C; Mas-Oliva J; Ortega A
Cell Physiol Biochem; 2012; 29(5-6):905-18. PubMed ID: 22613990
[TBL] [Abstract][Full Text] [Related]
17. The molecular cross talk of the dystrophin-glycoprotein complex.
Gawor M; Prószyński TJ
Ann N Y Acad Sci; 2018 Jan; 1412(1):62-72. PubMed ID: 29068540
[TBL] [Abstract][Full Text] [Related]
18. Dystroglycan expression in the wild type and mdx mouse neural retina: synaptic colocalization with dystrophin, dystrophin-related protein but not laminin.
Montanaro F; Carbonetto S; Campbell KP; Lindenbaum M
J Neurosci Res; 1995 Nov; 42(4):528-38. PubMed ID: 8568939
[TBL] [Abstract][Full Text] [Related]
19. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
Matsumura K; Campbell KP
Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
[TBL] [Abstract][Full Text] [Related]
20. The sarcolemma in the Large(myd) mouse.
Reed PW; Mathews KD; Mills KA; Bloch RJ
Muscle Nerve; 2004 Nov; 30(5):585-95. PubMed ID: 15389724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
